Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Global health security summit addresses pandemic medtech needs:

This article was originally published in Clinica

Executive Summary

The medical equipment needs of a potential pandemic influenza were among the subjects of an international summit of health ministers and other officials, held today in Rome, Italy. Among the decisions reached at the sixth ministerial meeting of the Global Health Security Initiative (GHSI) was a commitment to work with the World Health Organization "to develop and test protocols for early containment across a full range of public health interventions, including medical counter-measures and equipment". Other measures include a number of initiatives to ensure adequate information-sharing. The GHSI comprises health ministers and other senior officials from the Canada, France, Germany, Italy, Japan, Mexico, the UK and the US, together with the EU commissioner for health and representatives from the WHO.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057953

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel